Skip to content
Search

Latest Stories

RPS, Royal College of GPs publish recommendations to maximise potential of minor ailment referrals

Royal Pharmaceutical Society in England and the Royal College of General Practitioners have published recommendations for the roll-out and success of the GP Community Pharmacist Consultation Service (GP CPCS).

These recommendations follow a workshop with stakeholders from pharmacy, general practice and representative bodies, examining ways to maximise the potential of the service and meet growing demand on the health service.


The workshop report made five recommendations:

  • The NHS England and Improvement should provide additional investment in local system support and resources to drive the CPCS implementation and uptake between general practice and community pharmacy.
  • National representative bodies should work with NHS E&I to develop national and local engagement and streamline communication plans for CPCS referral pathway.
  • Focus on expanding the role of community pharmacists in the management of minor illness.
  • Evaluation of CPCS service and its impacts on general practice workload, patient outcomes and health inequalities.

THORRUN GOVIND Thorrun Govind, chair of RPS in England

Thorrun Govind, RPS England chair, said the service is “just one example of how we can use the skills of teams across community pharmacy, general practice and the wider NHS to help patients see the right clinician at the right time."

She noted that the last year has been “incredibly challenging" for the entire healthcare sector, and collaboration between GPs and community pharmacy can support patient care.

Govind said: “We know there are challenges to getting this right and it is fantastic that some of the recommendations are already being discussed with the NHS and other key partners as to how we can work together to achieve the best outcomes for patients.”

Professor Martin Marshall, chair of the Royal College of GPs, said that the CPCS is “potentially a part of the solutions” to meet growing patients’ demand without a sufficient workforce to meet demand.

“Pharmacists are highly-trained and highly-trusted healthcare professionals, who can play a vital role in supporting people with a range of minor ailments, freeing up GPs’ time for patients with complex health needs."

Hoping CPCS to become a success, Charlotte Augst, chief executive of National Voices, said it is important to enhance collaboration across primary care teams as pharmacists can “provide rapid access to help, advice and vital medicines.”

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less